Recently, the application of nanographene
oxide (nGO) as a drug delivery system has significantly increased. But, the rational engineering of nGO surface to improve its in vivo targeting and biodistribution remains mostly unexplored. In this study, we have prepared
folic acid conjugated
Pluronic for non-covalent functionalization of nanographene
oxide (nGO) sheets and active
tumor targeting. To modulate the
ligand density on the nGO surface, different ratios of
folate conjugated
Pluronic and unmodified
Pluronic were combined and used for coating nGO sheets. The surface density of targeting
ligand linearly increased as the relative amount of
folate conjugated
Pluronic was increased. The association of functionalized nGOs with
folate receptor overexpressing human epithelial mouth
carcinoma cells (KB cells) was evaluated by flow cytometry. Cellular uptake of nGO by KB cells increased steadily with the increase in
ligand density. In contrast, the in vivo experiment in mouse xenograft model did not show the steady increase in
tumor targeting by increasing
ligand density. Upon
intravenous administration into KB
tumor-bearing mice,
tumor accumulation of nGO did not show a significant targeting effect up to 25% of
ligand coating density. However, a strong and similar
tumor accumulation of nGO was observed for both 50% and 100%
folate coatings. Thus, a significant difference in
tumor accumulation of nGO was observed between the low
folate density groups and high
folate density groups, suggesting the existence of a critical
ligand density for
tumor targeting. The significant difference of
tumor targeting of nGO depending on
ligand density also resulted in the dramatic change in photothermal
tumor ablation by the irradiation of NIR
laser.